Calcium Channel Blockers
Calcium Channel Blockers is a pharmaceutical drug with 6 clinical trials. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study
Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study
Coronavirus (COVID-19) ACEi/ARB Investigation
Tocolysis in Prevention of Preterm Labor
Effect of Antihypertensive Agents Over Sleep Apnea
Clinical Trials (6)
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study
Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study
Coronavirus (COVID-19) ACEi/ARB Investigation
Tocolysis in Prevention of Preterm Labor
Effect of Antihypertensive Agents Over Sleep Apnea
Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6